Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
MINNEAPOLIS, April 20, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices for the treatment of lymphedema and chronic venous insufficiency, today announced that management will participate in the following investor conferences in May:
The Deutsche Bank 42nd Annual Health Care Conference at the InterContinental Hotel in Boston, MA
- Management will present on Thursday, May 4 at 9:20 a.m. Eastern Time.
The Bank of America Merrill Lynch 2017 Health Care Conference at the Encore at the Wynn Hotel in Las Vegas, NV
- Management will present on Thursday, May 18 at 10:00 a.m. Pacific Time.
Live audio webcasts of the presentations will be accessible under the ‘Events & Webcasts' section of the Company's investor relations website at http://investors.tactilemedical.com. Archives of the webcasts will be available for replay following the conferences.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices for the treatment of lymphedema and chronic venous insufficiency. Our unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our efforts help increase clinical efficacy, reduce overall healthcare costs, and improve the quality of life for patients with chronic conditions.
Investor Inquiries: Mike Piccinino, CFA Managing Director Westwicke Partners 443-213-0500 [email protected]
